Inactive Instrument

News WNTH AB Swiss Exchange

Equities

WNT

SE0003553130

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

Feb. 29	WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 29	WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioStock: WntResearch's new CEO comments on his first month in the position	Apr. 02	AQ
Resigning WntResearch CEO tells BioStock: "It will be exciting to follow!"	Mar. 01	AQ
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
WntResearch initiates collaboration with Business Sweden with the goal of establishing commercial partnerships for Foxy-5 in Japan and South Korea	Feb. 26	AQ
WntResearch Initiates Collaboration with Business Sweden with the Goal of Establishing Commercial Partnerships for Foxy-5 in Japan and South Korea	Feb. 26	CI
WntResearch continues to the next step in the phase 2 study NeoFox with the highest evaluated dose of Foxy-5	Feb. 12	AQ
WntResearch AB Continues to the Next Step in the Phase 2 Study Neofox with the Highest Evaluated Dose of Foxy-5	Feb. 12	CI
WntResearch announces the last day for trading in BTU and the first day for trading in warrants series TO 7 and warrants series TO 8	Feb. 08	AQ
WntResearch carries out a directed issue of units to underwriters in connection with the completed rights issue	Feb. 07	AQ
WntResearch publishes outcome in rights issue	Jan. 31	AQ
WntResearch's co-founder applies for subscription of additional units in the ongoing rights issue with a last day for subscription on 29 January 2024	Jan. 24	AQ
WntResearch Announces CEO Changes	Jan. 09	CI
WntResearch publishes prospectus in connection with rights issue	Jan. 08	AQ
Bulletin from the extraordinary general meeting in Wntresearch AB on 22 December 2023	Dec. 22	AQ
WntResearch continues to the second dose group in clinical proof of concept study of Foxy-5	Dec. 06	AQ
WntResearch Continues to the Second Dose Group in Clinical Proof of Concept Study of Foxy-5	Dec. 06	CI
WntResearch's CEO: "In a better position than ever"	Nov. 21	AQ
WntResearch AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
BioStock: WntResearch recruits first patient in restart of NeoFox	23-10-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News WNTH AB Swiss Exchange

Equities

WNT

SE0003553130

Summary

Filters